Tinctura Ginkgo bilobae Phytopharm

medicinal product

Heart, venous and peripheral circulation

Indications for use

A medicine traditionally used in peripheral blood circulation disorders.

Tinctura Ginkgo bilobae Phytopharm is a traditional herbal medicine and its efficacy is based only on experience from its long-lasting use.

100 ml of the liquid contains 100 ml of Ginkgo bilobae folii tinctura (1:5) – tincture from ginkgo biloba leaves.

Extraction solvent: ethanol 70 % (V/V).

Ethanol content in the medicinal product is 60-70 % (V/V).

Form: oral liquid
Packaging: 100 ml

Do not use in case of known hypersensitivity to products containing ginkgo biloba.

Not recommended in patients with increased bleeding tendency (blood coagulation disorders) or with haemophilia.

Phytopharm Klęka S.A., Klęka 1, 63-040 Nowe Miasto nad Wartą

Dosage and route of administration

Who?

Dose

When?

Adults

5-10 ml of the preparation

diluted in water

3 times per day

Want to learn more?

To jest lek. Dla bezpieczeństwa stosuj go zgodnie z ulotką dołączoną do opakowania. Zwróć uwagę na przeciwwskazania. W przypadku wątpliwości skonsultuj się z lekarzem lub farmaceutą.

Tradycyjny produkt leczniczy roślinny z określonymi wskazaniami wynikającymi wyłącznie z długotrwałego stosowania.

TGB/09/2024/1

We inform you that if you provide your personal data in order to contact us and receive a reply on your questions:
The controller of your data is Phytopharm Klęka S.A with the registered office at Klęka 1, 63-040 Nowe Miasto nad Wartą, entered into the register of entrepreneurs kept by the District Court in Poznań- Nowe Miasto and Wilda, 9th Commercial Division of the National Court Register (KRS) under KRS number 0000051392, NIP (tax identification number) 786-00-05-532, and you may contact us at the email address: welcome@europlant-group.pl;
In all matters related to processing of your personal data you can contact our Data Protection Officer at the email address: iod@europlant-group.pl;
Your personal data shall be processed in order to reply to the questions you sent in, i.e. based on the Controller’s legally justified interest connected with the necessity to immediately reply to letters (article 6 section 1 point f GDPR);
more